Navigation Links
Inverness Medical Innovations Acquires Alere Medical
Date:11/19/2007

WALTHAM, Mass., Nov. 19 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (Amex: IMA) today announced the completion of its acquisition of Alere Medical, Inc. at a purchase price of $302 million, comprising approximately $128 million in cash and $174 million in Inverness common stock and assumed options. Alere, headquartered in Reno, Nevada, provides health and care management services and programs to healthcare organizations in helping patients with chronic illnesses manage their conditions.

About Inverness

By developing new capabilities in near-patient diagnosis, monitoring and health management, Inverness Medical Innovations enables individuals to take charge of improving their health and quality of life. A global leader in rapid point-of-care diagnostics, Inverness' products, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. Inverness is headquartered in Waltham, Massachusetts. For additional information on Inverness Medical Innovations, please visit http://www.invernessmedical.com.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the federal securities laws, including statements regarding potential synergies and benefits of the proposed business combination and potential market growth. These statements reflect Inverness' current views with respect to future events and are based on Inverness' management's current assumptions and information currently available. Actual results may differ materially due to numerous factors including, without limitation, risks a
'/>"/>

SOURCE Inverness Medical Innovations
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Inverness Completes Acquisition of Cholestech
2. Inverness Medical Innovations Acquires Bio-Stat Healthcare Group
3. MSU engineering team designs innovative medical device
4. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
5. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
6. Owner and Operator of Florida Durable Medical Equipment Company Convicted of Medicare Fraud
7. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
8. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
9. Preparation for Natural Disasters Critical for People With Diabetes, Chronic Medical Conditions
10. Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment
11. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/6/2008)... WASHINGTON, Oct. 6 /PRNewswire-USNewswire/ -- ...nst several companies alleging that they,submitted...kbacks and the,establishment of sham durable medic...nt announced today. The companies are McKesson Cor...MediNet), GGNSC Holdings LLC,Golden Gate Ancillar...
(Date:10/6/2008)... A study led by researchers at the University of ...that use of oral Vitamin D supplements bolsters pr...n the skin, and may help prevent skin infections t...most common form of eczema. , The study led by ...and chief of the Division of Dermatology at the UC...
(Date:10/6/2008)... SAN DIEGO, Oct. 6 /PRNewswire/ -- Developed in... of Pacific Palisades, CA is introducing,Revolutio...y into the,Plastic Surgery office of Dr. Steve Lav... XS-300(TM), is the first of its kind, and is base...hnology combined with,innovative proprietary softw...
(Date:10/6/2008)... Vision Audio Inc. has an...deo game designed to help train children with auti...Se Off-Road is a fun, non-violent learning experie...participate in their enhanced sound-based therapy,...dio ( http://www.easecd.com ). , ...
Breaking Medicine News(10 mins):Health News:U.S. Intervenes in False Claims Act Suit Against McKesson Corp. and Golden Horizons Nursing Homes 2Health News:Oral vitamin D may help prevent some skin infections 2Health News:Plan Your Breasts in 3-D 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 3
...oger Williams has called for a ban on an artificia...tion of 6,000 types of medicines, food and drinks....he sweetener, which is used in cereal, chocolate a... Foundation has published reports that aspartame c...
...i Ramachandra Medical College and Research Institu... LifeCell have announced a joint venture towards e...lity in the city.// The umbilical cord blood stem ...ard to treating a variety of diseases. The focus o...
...licted with the Alzheimer's disease is expected to...y and the population explosion in developing natio...mentia which is connected to cardiovascular diseas...igure is expected to rise to 42 million, and to 81...
...e Mellon University have reported in the Journal P...s and being happy protects from chronic illness an...ch study was led by Professor Sheldon Cohen team w...lth as they feel that it enhances the immune syste...
Other Medicine News:
(Date:10/6/2008)...ial Showed REMICADE Therapy is More Likely to Indu...mpared with Standard Immunomod...wswire/ -- Data presented for the first time,from ...e Naive to,Immunomodulators and Biologic Therapy (...to care of patients with moderate to severe Crohn,...
(Date:10/6/2008)...netic Characteristics of Naltrexone SR Associated ...l Trials -, PHOENIX, Oct. 6 /PRNewswire-FirstCall... a biopharmaceutical company focused on the treatm...lated disorders, today presented,data showing the ...,bupropion SR), successfully achieved key objectiv...
(Date:10/5/2008)... in New England Journal of Medicine reaffirm,well-...of SPIRIVA(R),HandiHaler(R), RIDGEFIELD, Conn., a...,UPLIFT (Understanding Potential Long-term Impacts...PIRIVA(R) HandiHaler(R) (tiotropium bromide,inhala...ion for up to 4,years as measured by FEV(1) (p<0.0...
(Date:10/2/2008)...rgent PC clinical success and expanded reimburseme...APOLIS, Oct. 2 /- Uroplasty...of the first patients in a new,randomized, control...Urgent,PC neuromodulation system for the treatment...rgency, urge incontinence and frequency of urinary...
Breaking Medicine Technology:New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 2New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 3New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 4New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 5New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 6New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 7New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 8Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 2Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 3Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 4Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 5Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 2Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 3Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 4Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 5Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 6Uroplasty Enrolls First Patients in Urgent(R) PC Clinical Trial 2Uroplasty Enrolls First Patients in Urgent(R) PC Clinical Trial 3Uroplasty Enrolls First Patients in Urgent(R) PC Clinical Trial 4Karmanos Researchers Study the Impact of Galectin 3 on Breast Cancer Disparity in Caucasian and Asian Women 1768 1Karmanos Researchers Study the Impact of Galectin 3 on Breast Cancer Disparity in Caucasian and Asian Women 1768 2Karmanos Researchers Study the Impact of Galectin 3 on Breast Cancer Disparity in Caucasian and Asian Women 1768 3Stem Cell Marker Controls Pair of Key Cancer Pathways 16714 1Stem Cell Marker Controls Pair of Key Cancer Pathways 16714 2Celebrex Lipitor combo may halt prostate cancer 16711 1Celebrex Lipitor combo may halt prostate cancer 16711 2Celebrex Lipitor combo may halt prostate cancer 16711 3Decrease in mortality after severe injuries in accidents 16708 1
..., 2007 /PRNewswire/ -- D-Pharm announced,today tha...protective compound DP-b99 in the treatment of acu...he European Stroke,Conference. The data will be pr...or Prof. H. C. Diener, on Thursday May 31st at,14....Conference,Center in Glasgow. The abstract for the...
...RNewswire-USNewswire/ -- Evidence is,accumulating ...,reports the June 2007 issue of Harvard Women,s He...50 and over who regularly took,antidepressants cal...) had double the rate of fractures as people not u...pression itself as a source,of endocrine changes t...
Other Medicine Technology:DP-b99 Phase IIb Trial Results to be Presented at the European,Stroke Conference 2DP-b99 Phase IIb Trial Results to be Presented at the European,Stroke Conference 3Antidepressant Use May Boost Fracture Risk, From Harvard Women's,Health Watch 2
IMMULITE and IMMULITE 1000 assays are designed for use with the IMMULITE and IMMULITE 1000, continuous random access immunoassay analyzers which offer simplicity in both design and operation. IMMULIT
The C-Reactive Protein (CRP) assay is used for the quantitative analysis of C-reactive protein in human serum and plasma. Kit is for use with the Abbot Laboratories Aeroset, ARCHITECT c8000 or ARCHI
LabDAQ3 opens new windows for the laboratory in flexibility, communication, security, and value. Users can easily move from one function to another. You can review results, validate QC, order tests,
...y for faster, easier, and more accurate automated ...lizes the latest digital FireWire technology, allo... Its ease of use allows technicians to read plates...reduction frees technicians to perform other impor...
Medicine Products: